ESR1 and breast cancer: Such a mechanism was demonstrated by Tian X. and Zhang Z. In detail, estrogen-induced miR-191 targeted and decreased the expression of DAB2 and led to the promotion of cellular proliferation of ER+BC cells in vitro.